Self Paced

Strategies To Improve Glucose Control with Mealtime Insulin

Learn from expert clinicians how to initiate and optimize mealtime insulin, compare second-generation ultra-rapid insulin analogs with older therapies, and celebrate cultural heritage while maintaining glucose control.

NCQA partnered with the Medical Learning Institute, Inc. and the Endocrine Society on this unique continuing education initiative.

This CME/NCPD/CPE activity is comprised of five individual interactive, microlearning modules addressing care and outcomes for individuals with diabetes with mealtime insulin (MTI). The modules will incorporate case studies with embedded questions for an active learning experience. Learners can choose to participate in one or more of the modules to address their educational interests and needs based on their scope of practice and patient population.

Module 1: Initiating MTI Therapy (0.25 credits/contact hours)
  • Importance of MTI to maintain a more normoglycemic profile
  • Selection of appropriate patients for MTI
  • Use of CGM to assess effectiveness
Module 2: Optimizing MTI Therapy (0.25 credits/contact hours)
  • Improving PPG and TIR
  • Application of real-world evidence to improve control

Module 3: Second Generation Rapid-Acting Insulin Analogs for MTI Therapy (0.5 credits/contact hours)

  • Older analogs—benefits and risks
  • Newer insulin analogs

Module 4: Improving Glucose Control with MTI in Culturally Diverse Populations (0.25 credits/contact hours)

  • Factor of cultural heritage that may affect treatment efficacy
  • Potential strategies to celebrate cultural foods and traditions while adhering to a diabetic diet and MTI therapy

Module 5: Overcoming Barriers to MTI (0.25 credits/contact hours)

  • Approaches to engage patients in decision making
  • Anticipating and responding to patient questions and fears
  • Strategies to improve adherence and satisfaction with therapy

Method of Participation

There are no fees for participating in or receiving credits/contact hours for this accredited CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Requirements for Successful Completion

In order to receive credit, learners can participate in one or more of the Modules.  Learners will receive the applicable credits/contact hours indicated for their participation in each Module with a maximum of 1.5 credits/contact hours for all 5 Modules. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed upon completion. You will receive your certificate from [insert email]. Please check your spam and junk mail to ensure receipt. 

If you have questions regarding the receipt of your emailed certificate, please contact via email at ndane@mlicme.org.

For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: https://nabp.pharmacy/

Speakers

Jennifer Hall, MS, RDN, LDN, CDCES
Registered Dietitian/Certified Diabetes Care and Education Specialist
FOunder, Owner and CEO of DANS-Diabetes and Nutrition Services, LLC
Little Rock, AR

Juan Pablo Frias, MD
Medical Director
Nationla Research INstitute
Los Angeles, CA

Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP
Adjunct Associate Professor of Pharmacy Practice
Endocrine Clinical Pharmacy Specialist
Massachusetts COllege of Pharmacy
Boston, MA

Jay Shubrook, DO, FACOFP, FAAFP
Professor, Primary Care Department
Touro University California
Vallejo, CA

Katherine Whitmire, NP-C, BC-ADM, CDCES
Nurse Practitioner
Endocrinology Department
Southwest Medical Associates
Las Vegas, NV

Accreditation and Disclosure Information

Target Audience

This accredited CE activity is intented for endocrinologists and primary care clinicians including NPs, PAs, residents, fellows, nurses, diabetes educators, and other allied professionals who provide care for individuals with T1D or T2D eligible for or treated with MTI.
 
Educational Objectives
After completing this accredited CE activity, the participant should be better able to:
  • Assess recent data and best practices regarding timely and effective initiation of MTI therapy
  • Identify appropriate candidates for transitioning to MTI therapy
  • Differentiate conventional rapid acting insulins from ultra-rapid analogs
  • Devise individualized treatment strategies to optimize control of PPG levels and TIR with new rapid-acting insulin analogs
  • Evaluate new and emerging data regarding the MOA, PK/PD profiles, and safety and efficacy of novel rapid-acting insulin analogs
  • Plan strategies to integrate robust measures of glucose control, including real world evidence, into treatment planning
  • Develop strategies to maintain glucose control with MTI therapy while celebrating cultural foods and traditions

Physician Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., the Endocrine Society and National Committee for Quality Assurance (NCQA).  Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development Contact Hours

Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours and 1.5 contact hours in the area of pharmacology.

Continuing Pharmacy Education Contact Hours

Medical Learning Institute, Inc. (MLI) designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA0007322-0000-21-009-H01-P
Type of Activity: Knowledge
 

Interprofessional Continuing Education Credit

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Commercial Support Statement

This activity is supported by an educational grant from Lilly.

Disclosure & Conflict of Interest Policy

Medical Learning Institute, Inc., is committed to providing high quality accredited continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this accredited CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this accredited CE activity, regardless of the amount or their view of the relevance to the accredited education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the accredited CE activity. 

Planner/Presenter

Juan Pablo Frias, MD, National Research Institute, Los Angeles, CA

Juan Pablo Frias, MD, has a financial interest/relationship or affiliation in the form of:

Consultant and/or Advisor for 89Bio, Akero, Altimmune, Axcella Health, Becton Dickenson, Boehringer Ingelheim, Carmot Therapeutics, Echosens, Eli Lilly, Gilead, Merck, Metacrine, Novo Nordisk, Pfizer, Sanofi

Grant/Research Support from Akero, Abbvie, AstraZeneca, Boehringer Ingelheim, BMS, Eli Lilly, Intercept, Janssen, Madrigal, Merck, Metacrine, NorthSea, Novartis, Novo Nordisk, Oramed, Pfizer, Poxil, Sanofi

Speakers Bureau participant with Merck, Novo Nordisk, Sanofi

Planner/Presenter

Jennifer Hall, MS, RDN, LDN, CDCES, Nutrition Services, LLC, Little Rock, Arkansas

Jennifer Hall, MS, RDN, LDN, CDCES has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.

Planner/Presenter

Dhiren Patel, PharmD, CDCES, BC-ADM, Massachusetts College of Pharmacy, Boston, MA

Dhiren Patel, PharmD, CDCES, BC-ADM, has a financial interest/relationship or affiliation in the form of:

Consultant and/or Advisor for Abbott, Amarin, Astra Zeneca, Bayer, Boehringer Ingelheim, Dexcom, Insulet, Lilly, Merck, Novo Nordisk, Sanofi, Xeris, Zealand

Speakers Bureau participant with Abbott, Amarin, Astra Zeneca, Bayer, Boehringer Ingelheim, Dexcom, Insulet, Lilly, Merck, Novo Nordisk, Sanofi, Xeris, Zealand

Planner/Presenter

Jay Shubrook, DO, FAAFP, Touro University California, Vallejo, CA

Jay Shubrook, DO, FAAFP, has a financial interest/relationship or affiliation in the form of:

Consultant and/or Advisor for Astra Zeneca, Bayer, Eli Lilly

Planner/Presenter

Katherine H Whitmire, NP-c, BC-ADM, CDCES, Southwest Medical Associates, Las Vegas, NV

Katherine H Whitmire, NP-c, BC-ADM, CDCES has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity. 

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc. and the Endocrine Soceity the accredited providers, and National Committee for Quality Assurance, the joint provider does not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this accredited CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this accredited CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 
Disclosure of Unlabled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this accredited CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Event Type
  1. Self Paced
Policies and Discounts

Includes the printable registration form, substitutions, transfers/credits and cancellation policies as well as other education policies and discount information.

Read Policies
Publications & Products

View all NCQA publications and products, including HEDIS manuals, Accreditation standards and NCQA newsletters.

View All
Customer Support

NCQA Customer Support is available Monday – Friday, 8:30 – 5:00 ET M-F.
Call: 888.275.7585

Contact NCQA
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

Have a Team?
Get Virtual Team Training

NCQA can bring virtual or in-person training to you and your team of 20 people or more.